Juan Esteban Correa-Morales, Maria Alejandra Umbacia, Catalina Martinez, Ignacio Zarante, Aurora Marixa Guerrero Liñeiro, Sara Giraldo-Moreno, Marta Ximena León
{"title":"姑息治疗在低患病率疾病中的首要作用。","authors":"Juan Esteban Correa-Morales, Maria Alejandra Umbacia, Catalina Martinez, Ignacio Zarante, Aurora Marixa Guerrero Liñeiro, Sara Giraldo-Moreno, Marta Ximena León","doi":"10.12968/ijpn.2023.0039","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Low-prevalence diseases (LPDs), previously referred to as orphan diseases or rare diseases, entail a substantial potential for mortality and impose a remarkable burden of symptoms for patients. The process of diagnosing these diseases is often lengthy, and viable treatment options for such conditions are scarce, or in some cases, non-existent.</p><p><strong>Methods: </strong>A narrative review was carried out following the Scale for the Assessment of Narrative Review Articles (SANRA) methodology to establish the role of palliative care in the treatment and follow-up of patients with LPDs. A search was carried out by a multidisciplinary team in EMBASE, PUBMED, Web of Science, CINHAL and OVID. Peer-reviewed articles reporting on the role of palliative care in the multidisciplinary treatment of LPDs were included.</p><p><strong>Results: </strong>The review identified significant areas where palliative care specialists play a crucial role in caring for LPDs. These areas include addressing complex physical and emotional symptoms, assisting patients in adjusting their expectations through genetic counselling, facilitating decision-making across short, medium and long-term perspectives based on disease prognosis, and offering support with care transitions, advanced planning and the grieving process for families.</p><p><strong>Conclusion: </strong>Patients with LPDs and their caregivers experience complex care needs that should be assessed by a palliative care specialist and supported by a multidisciplinary medical group.</p>","PeriodicalId":94055,"journal":{"name":"International journal of palliative nursing","volume":"31 4","pages":"181-188"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The paramount role of palliative care in low-prevalence diseases.\",\"authors\":\"Juan Esteban Correa-Morales, Maria Alejandra Umbacia, Catalina Martinez, Ignacio Zarante, Aurora Marixa Guerrero Liñeiro, Sara Giraldo-Moreno, Marta Ximena León\",\"doi\":\"10.12968/ijpn.2023.0039\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Low-prevalence diseases (LPDs), previously referred to as orphan diseases or rare diseases, entail a substantial potential for mortality and impose a remarkable burden of symptoms for patients. The process of diagnosing these diseases is often lengthy, and viable treatment options for such conditions are scarce, or in some cases, non-existent.</p><p><strong>Methods: </strong>A narrative review was carried out following the Scale for the Assessment of Narrative Review Articles (SANRA) methodology to establish the role of palliative care in the treatment and follow-up of patients with LPDs. A search was carried out by a multidisciplinary team in EMBASE, PUBMED, Web of Science, CINHAL and OVID. Peer-reviewed articles reporting on the role of palliative care in the multidisciplinary treatment of LPDs were included.</p><p><strong>Results: </strong>The review identified significant areas where palliative care specialists play a crucial role in caring for LPDs. These areas include addressing complex physical and emotional symptoms, assisting patients in adjusting their expectations through genetic counselling, facilitating decision-making across short, medium and long-term perspectives based on disease prognosis, and offering support with care transitions, advanced planning and the grieving process for families.</p><p><strong>Conclusion: </strong>Patients with LPDs and their caregivers experience complex care needs that should be assessed by a palliative care specialist and supported by a multidisciplinary medical group.</p>\",\"PeriodicalId\":94055,\"journal\":{\"name\":\"International journal of palliative nursing\",\"volume\":\"31 4\",\"pages\":\"181-188\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-04-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International journal of palliative nursing\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12968/ijpn.2023.0039\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of palliative nursing","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12968/ijpn.2023.0039","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景:低流行率疾病(lpd),以前被称为孤儿病或罕见病,具有巨大的潜在死亡率,并给患者带来显著的症状负担。诊断这些疾病的过程往往很漫长,而且针对这些疾病的可行治疗方案很少,或者在某些情况下根本不存在。方法:采用叙事回顾文章评估量表(SANRA)方法进行叙事回顾,以确定姑息治疗在lpd患者治疗和随访中的作用。一个多学科小组在EMBASE、PUBMED、Web of Science、CINHAL和OVID中进行了搜索。同行评议的文章报道了姑息治疗在lpd多学科治疗中的作用。结果:该综述确定了姑息治疗专家在护理lpd方面发挥关键作用的重要领域。这些领域包括处理复杂的身体和情绪症状,通过遗传咨询帮助患者调整他们的期望,根据疾病预后促进短期、中期和长期的决策,并在护理过渡、高级规划和家属悲伤过程方面提供支持。结论:lpd患者及其护理人员经历复杂的护理需求,应由姑息治疗专家评估并由多学科医疗小组提供支持。
The paramount role of palliative care in low-prevalence diseases.
Background: Low-prevalence diseases (LPDs), previously referred to as orphan diseases or rare diseases, entail a substantial potential for mortality and impose a remarkable burden of symptoms for patients. The process of diagnosing these diseases is often lengthy, and viable treatment options for such conditions are scarce, or in some cases, non-existent.
Methods: A narrative review was carried out following the Scale for the Assessment of Narrative Review Articles (SANRA) methodology to establish the role of palliative care in the treatment and follow-up of patients with LPDs. A search was carried out by a multidisciplinary team in EMBASE, PUBMED, Web of Science, CINHAL and OVID. Peer-reviewed articles reporting on the role of palliative care in the multidisciplinary treatment of LPDs were included.
Results: The review identified significant areas where palliative care specialists play a crucial role in caring for LPDs. These areas include addressing complex physical and emotional symptoms, assisting patients in adjusting their expectations through genetic counselling, facilitating decision-making across short, medium and long-term perspectives based on disease prognosis, and offering support with care transitions, advanced planning and the grieving process for families.
Conclusion: Patients with LPDs and their caregivers experience complex care needs that should be assessed by a palliative care specialist and supported by a multidisciplinary medical group.